Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages

Glioma represents the most common primary intracranial malignancy worldwide, with low overall survival rates and limited therapeutic options. The protein CD101, mainly expressed on several immune cells, has been demonstrated to exert potent effects on blunting T cell immune responses across infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuyang, Yao, Renqi, Shi, Ying, Liu, Yuxiao, Liu, Hongyu, Liu, Jialin, Guan, Yunqian, Yao, Yongming, Chen, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957828/
https://www.ncbi.nlm.nih.gov/pubmed/35350788
http://dx.doi.org/10.3389/fimmu.2022.845223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957828/
https://www.ncbi.nlm.nih.gov/pubmed/35350788
http://dx.doi.org/10.3389/fimmu.2022.845223

Ejemplares similares